HOME >> MEDICINE >> NEWS
Combined Therapy Improved Care Of Patients With Type 2 Diabetes Proper Use Of,,New Oral Medications Evaluated

NEW HAVEN, Conn., March 26, 1998-When patients with type 2 diabetes took two new medications together, rather than separately, they experienced further improvement in controlling their blood glucose levels, according to a new study conducted by researchers at Yale University School of Medicine and the Howard Hughes Medical Institute at Yale.

"The medications that we studied-metformin and troglitazone-act in different ways in the human body and were equally effective in lowering patients' blood glucose levels," explains Gerald I. Shulman, M.D., Ph.D., professor of medicine (endocrinology) and of cellular and molecular physiology at Yale and an investigator with the Howard Hughes Medical Institute. "The combined therapy was logical and reversed two abnormalities that patients with this disorder experience. Metformin acted primarily to decrease the patients' liver glucose production, while troglitazone worked primarily to enhance the ability of the patients' muscle to respond to insulin and take up glucose."

The findings are reported in the March 26 issue of The New England Journal of Medicine, published by the Massachusetts Medical Society. The study itself was conducted in Yale's federally supported General Clinical Research Center. Glucose, a simple sugar, serves as an important source of energy in the human body, as well as an important source of energy for the brain. People with diabetes experience higher than normal blood glucose levels, which can lead to complications.

Type 2 diabetes, the most common type of diabetes, is considered to be the leading cause of blindness, renal failure and loss of limb, according to the American Diabetes Association (ADA). It also is the fourth leading cause of death. Approximately $85 billion a year are estimated to be spent on direct diabetes care.

Type 2 diabetes affects about 15 million Americans, the ADA estimates. Approximately seven million Americans have b
'"/>

Contact: Helaine Patterson or Karen Peart
helaine.patterson@yale.edu
203 785-5824
Yale University School of Medicine
26-Mar-1998


Page: 1 2

Related medicine news :

1. Combined drug therapy prevents progression of prostate enlargement
2. Combined therapies benefit heart failure patients
3. Combined kidney and bone marrow transplantation allows patients to discontinue anti-rejection drugs
4. Combined Use Of New, Non-Invasive Screening Techniques In First Trimester May Yield Earlier Evidence Of Fetal Birth Defects
5. University Of Texas Southwestern Studies Excimer Laser For Treating Farsightedness With Combined Astigmatism
6. Prospects For Surviving Heart Attack Emergency Improve When Clot-Busting Drugs Are Combined With Balloon Pump Inserted In Aorta
7. UT Southwestern Moncrief Cancer Center is first in Texas to treat patients with TomoTherapy
8. Therapy, medication combination superior for children with obsessive-compulsive disorder
9. Oncology Nursing Society honors Fox Chase Cancer Center nurse with Radiation Therapy Nursing Award
10. Therapy for mice with prion disease could offer benefit to human beings with CJD
11. Vagus Nerve Stimulation Therapy (TM) more effective in epilepsy patients when used earlier

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/15/2019)... ... November 15, 2019 , ... ... webinar on comprehensive school physical activity programs (CSPAP) on December 3, 2019 at ... recreation and park professionals, this one-hour and 15-minute webinar will discuss the five ...
(Date:11/14/2019)... ... , ... With Giving Tuesday on Dec. 3, 2019, the ... about the benefits of supporting local hospitalized veterans throughout Maryland. Created in 2012, ... to give, collaborate and celebrate generosity before the holidays, and enables participants to ...
(Date:11/14/2019)... ... November 14, 2019 , ... BioInformatics Inc., part of Science and ... today announced that 7 companies have been nominated for a Life Science Industry ... Since 2002, the Life Science Industry Awards have recognized manufacturers of the “tools of ...
(Date:11/12/2019)... Ind. (PRWEB) , ... November 12, 2019 , ... ... a select group of individuals/organizations who have truly impacted those diagnosed with infertility. ... received RESOLVE’s prestigious Hope Award for Achievement, presented at the Night of Hope ...
(Date:11/12/2019)... ... 2019 , ... The quality of study start-up can dictate ... contract negotiations and 80 percent of organizations still using spreadsheets to track activities, ... improvement. Following an overview of the challenges facing trial sponsors, this webinar will ...
Breaking Medicine News(10 mins):
(Date:11/11/2019)... ... November 11, 2019 , ... PRP Science , Florida’s ... is now representing two of the most respected manufacturers in the medical aesthetics arena; ... Ameia Med is the leading developer of the EXCEED micro-needling device ...
(Date:11/11/2019)... ... November 11, 2019 , ... Attorneys representing an ... statement before U.S. Bankruptcy Court Judge Robert Drain in White Plains, NY notifying ... prescription opioid epidemic cannot be forgotten as a $12 billion settlement is considered. ...
(Date:11/11/2019)... ... November 11, 2019 , ... Over 60 schools in the northwest panhandle of ... program is designed to provide virtual mental health care to more than 35,000 students ... in October of 2018 [1]. , “This initiative by the state of Florida,” says ...
Breaking Medicine Technology:
Cached News: